Publications found:
36,694
Sort by:
Global Pharmaceutical & Biotechnology Outlook 2011
US$ 10,000.00
... strategic and long term investment decision making of senior management. Outlook-11’ has been tailored to deliver more meaningfully in the ... for the future, and their key milestones. The Global Pharmaceutical Model is changing. Major pharmaceutical companies continue to under-perform in a market constrained ...
December 2010
454 pages
Pharma YouTube Channels: Content and Comment
US$ 395.00
Popular video sharing site YouTube is the third busiest website in the world, visited by almost 109 million unique users each month. Nearly a day and a half's worth of content is uploaded by users on...
December 2010
81 pages
Bromides Applied in Pharmaceuticals Production in China
US$ 325.00
... the strong demand from production of bromides, China’s bromine industry had developed rapidly before 2007. Since 2008, China’s bromine output has ... a lot, which has largely impacted the production of bromides in China. Although China’s bromine and bromides industry has been heavily impacted by the global ...
December 2010
7 pages
Pharma Marketing in Latin America
US$ 395.00
Unified by geography, culture and language, Latin America nevertheless remains a marketing puzzle for the pharmaceutical industry. Although the Internet is increasing in popularity, it is available on...
November 2010
43 pages
TOP 10 Drug Discovery Technologies – Strategic Analysis and Global Forecasts
US$ 3,390.00
Top 10 drug discovery technologies – strategic analysis and global forecasts (2010 to 2015) The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical ... of new blockbuster drugs is a major concern which the drug development companies are catering to by using these top technologies. The global top 10 drug discovery technologies market is expected ...
November 2010
311 pages
Booming US Generic Drug Market
US$ 1,000.00
Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,600.00 Hard Copy: US$ 1,200.00 CD-ROM: US$ 1,200.00 The US represents one of the world’s largest economies. The countries per capita inc...
October 2010
50 pages
The 2011 Top Ten World’s Leading Pharmaceutical Companies
US$ 10,560.00
... To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading pharmaceutical companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis ...
October 2010
1200 pages
The 2011 Leading Pharmaceutical Companies Strategic Directions
US$ 1,480.00
... product development, and marketing objectives and strategies. Anticipated acquisitions, joint ventures and divestitures. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
45 pages
The 2011 Leading Pharmaceutical Companies Financial Analyses
US$ 1,480.00
... , geographic region, therapeutic category, and individual drug. Five-year sales and operating profit performance. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis ...
October 2010
130 pages
The 2011 Leading Pharmaceutical Companies Collaborative Arrangements
US$ 1,480.00
... , and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
200 pages
The 2011 Leading Pharmaceutical Companies Technological Know-How
US$ 1,480.00
... capabilities. Know-how in biotechnology and other pertinent fields. Proprietary technologies and patent litigations. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
50 pages
The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses
US$ 1,480.00
... review of major ethical, OTC, and generic drugs. Most recent new drug introductions and indications. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis - ...
October 2010
275 pages
The 2011 Leading Pharmaceutical Companies Marketing Tactics
US$ 1,480.00
... force in the U.S., Europe, Asia, and other geographic regions. Distribution strategies. Major promotional tactics. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis ...
October 2010
60 pages
The 2011 Leading Pharmaceutical Companies Comparative Analysis
US$ 680.00
Global PDF: US$ 1,900.00 This report ranks the world’s major pharmaceutical companies according to the following criteria: Sales and market shares. Operating profit and margins. R&D expenditures and percent of sales. The companies analyzed in the report: - AstraZeneca - Bristol- ...
October 2010
-
Opthalmic Pharmaceutical Drugs: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ million by the following Therapeutic Categories: Glaucoma, Anti-allergy, Anti- ... through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 95 companies including many key and niche ...
October 2010
565 pages
Analgesics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Analgesics in US$ Million by the following segments: Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others ( ... AG, Pfizer, Inc., Reckitt Benckiser Group Plc, and Sanofi Aventis S.A. Market data and analytics are derived from primary and secondary ...
October 2010
767 pages
Antibiotics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Antibiotics in US$ Million by the following product segments: Penicillin, Cephalosporins, Macrolides, Quinolones, Carbapenems, and ... 2015. A seven-year historic analysis is also provided for these markets. The report profiles 197 companies including many key and ...
October 2010
850 pages
China Vaccine Industry Report, 2009-2010
US$ 1,900.00
Price:Hard Copy: US$ 1,900.00 PDF for Single User: US$ 2,000.00 PDF for Enterprisewide: US$ 3,000.00Being one of the world's largest vaccine producers, China not only has many vaccine companies, vari...
September 2010
111 pages
Global and China Biopharmaceutical Industry Report, 2010
US$ 2,000.00
In recent years, biopharmaceutical industry has been the fastest growing sector in the global pharmaceutical industry. From 1998 to 2009, the compound annual growth rate of biopharmaceutical industry...
September 2010
121 pages
Pharma Market Insights: Generics
US$ 1,645.00
FirstWord Market Intelligence Collections
Biosimilars. Biobetters. Branded and generic drugs. Specialty generics. Pay-for-delay.
Individually, they represent big questions for the...
September 2010
260 pages
Pharmaceutical Market Access in Latin America
US$ 395.00
With its top eight markets valued at more than $30 billion in 2009, Latin America represents shining hope for an industry in flux. Strong, steady growth, resiliency in the face of global downturn, pos...
August 2010
58 pages
Effective Social Media Marketing Strategies for Pharmaceutical Market
US$ 3,390.00
... provides in-depth social media usage in pharmaceutical industry and analyses top 20 pharmaceutical players individually, for their social media presence. Further effective social media strategies are discussed in detail that can be useful in developing a successful social media campaign for pharmaceutical market. Benefits, Risks and Future impact of social media ...
August 2010
146 pages
R&D Drug Pipeline Database: 2-Months Subscription
US$ 2,300.00
... and e-mail support will be provided. Benefits from the R&D Drug Pipeline Database: New database with no historical burden Intuitive use Designed for ... Targets of the Scroll Down Menu: Anti-Infective Antibodies Antibody-Drug Conjugates (ADC) Biologic & Immune Therapy of S. aureus Infections c-MET/HGF ...
August 2010
-
Sleeping Pills: Market Research Report
US$ 3,950.00
This report analyzes the Global market for Sleeping Pills in US$ Million. Annual estimates and forecasts are provided for the period of 2007 ... Inc., Synthon BV, Takeda Pharmaceutical Company Limited, and Transcept Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. ...
August 2010
354 pages
Protein Drugs: Market Research Report
US$ 3,950.00
This report analyzes the Global market for Protein Drugs in US$ Million by the following Drug Classes - Antibodies, Blood Products, Cytokines, Peptide Hormones, ... -Plough Corporation, UCB Group, Unigene Laboratories, Inc., and Vaccinogen, Inc. Market data and analytics are derived from primary and secondary ...
August 2010
524 pages
Drugstores: Market Research Report
US$ 3,950.00
... the worldwide markets for Drugstores in US$ Billion. The US market is further analyzed by the following categories: Chain Drugstores, Independent Drugstores, and Mail ... 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 95 companies including many key and niche ...
July 2010
293 pages
Pharma Sales Forces: Mexico
US$ 295.00
Enchiladas, cerveza, sombreros and ponchos: Forget what you thought you knew about Mexico. With the 11th largest economy in the world and a pharmaceutical industry expected to hit $14.9 billion by 201...
June 2010
45 pages
Competitor Analysis: Streptococcal Vaccines and Antibodies
US$ 230.00
... A Streptococcus Group B Streptococcus Other Streptococcal Vaccine & Antibody R&D Agreements Corporate Streptococcal Vaccines & Antibody R&D Pipelines About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D ...
June 2010
18 pages
Competitor Analysis: P. aeruginosa Vaccines and Therapeutics
US$ 230.00
... P. aeruginosa Peptides P. Aeruginosa Small Molecules P. aeruginosa R&D Licensing Agreements Corporate P. aeruginosa Vaccines & Therapeutics R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of ...
June 2010
22 pages
Pharma 2.0 -- De-Risking the Business Model
US$ 395.00
Adapt. Evolve. Survive. Darwinian Theory as a business model for the pharmaceutical industry? Never has it been more apt—or timely. As it enters one of its most challenging periods ever, the pharmaceu...
May 2010
44 pages
Global Bio-Pharma CMO Market Report
US$ 700.00
... technologies. The global bio-pharma CMO market has witnessed high growth over the last few years. The share of the CMO market of the total Bio-Pharma market has also ...
May 2010
32 pages
